Daryl Hutchinson, MD
Gastroenterology · Sun City, AZNPI 1881689792
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 138 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 27.5% of the total. That places this record below the midpoint for gastroenterology clinicians in AZ, where the typical reported total is $3,568.
Across 138 payments — averaging $22.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$852
- Sanofi$606
- Pfizer$276
- Madrigal Pharmaceuticals$246
- Gilead$167
- Amgen$133
- plus $821 from 14 others
Across 11 payments — averaging $8209.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$49K
- Braintree Laboratories, Inc.$41K
What the payments were for
- Food & beverage$3,00397%
- Education$993%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 46 | $852 |
| Sanofi | 21 | $606 |
| Pfizer | 15 | $276 |
| Madrigal Pharmaceuticals | 9 | $246 |
| Gilead | 10 | $167 |
| Amgen | 5 | $133 |
| Bristol Myers Squibb | 6 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $120 |
| Johnson & Johnson | 2 | $117 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $111 |
| Medtronic | 2 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
| Endogastric Solutions, Inc | 1 | $52 |
| Exelixis Inc. | 1 | $44 |
| Shionogi Inc | 2 | $36 |
| Novo Nordisk | 1 | $22 |
| Shire North American Group Inc | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| CSL Behring | 1 | $15 |
How this compares
$3,102 in reported general payments places this provider in the 45th percentile of 355 gastroenterology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 14 | $358,243 |
| Humira(Cf) PenAdalimumab | 15 | $217,564 |
| Humira PenAdalimumab | 12 | $155,327 |
| CreonLipase/Protease/Amylase | 33 | $148,007 |
| OcalivaObeticholic Acid | 12 | $111,087 |
| XifaxanRifaximin | 31 | $91,475 |
| LinzessLinaclotide | 52 | $55,108 |
| CholestyramineCholestyramine (With Sugar) | 77 | $9,631 |
| Mesalamine | 26 | $6,870 |
| Budesonide EcBudesonide | 18 | $6,700 |
| Mesalamine ErMesalamine | 16 | $5,967 |
| Budesonide DrBudesonide | 31 | $4,337 |
| Pantoprazole Sodium | 240 | $4,322 |
| Omeprazole | 262 | $3,708 |
| Balsalazide Disodium | 15 | $2,931 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $117 | $358,24314 claims |
| AbbVieCreon, Linzess | $852 | $203,11585 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $111 | $91,47531 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 355 gastroenterology providers in Arizona.
Other gastroenterology in Sun City
- Chirag TrivediSun City$400K
- Keng-Yu ChuangSun City$14K
- Joel BrillParadise Valley$847K
- Daniel MelineScottsdale$795K
- David FleischerScottsdale$410K
- Neil SharmaGilbert$405K
- David LeffMesa$377K
- Pankaj PasrichaScottsdale$304K
- Norio FukamiScottsdale$215K
- Toufic KachaamyScottsdale$210K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.